Identification of N-homocysteinylation sites in plasma proteins

Amino Acids

Volumn 46, Issue 1, 2014, Pages 235-244

  Sikora, Marta ^a   Marczak, Łukasz ^a   Kubalska, Jolanta ^b   Graban, AŁŁa ^b   Jakubowski, Hieronim ^a,c,d  

^a INSTITUTE OF BIOORGANIC CHEMISTRY   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^c POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Homocysteine thiolactone; Human albumin; Human fibrinogen; Mass spectrometry; N homocysteinylation

Indexed keywords

BLOOD PROTEINS; HOMOCYSTEINE; HOMOCYSTINURIA; HUMANS; PEPTIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84895909640     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-013-1617-7     Document Type: Article

References (32)

1. Chwatko G, Boers GH, Strauss KA, Shih DM, Jakubowski H (2007) Mutations in methylenetetrahydrofolate reductase or cystathionine beta-synthase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice. Faseb J 21(8):1707-1713
2. Glowacki R, Jakubowski H (2004) Cross-talk between Cys34 and lysine residues in human serum albumin revealed by N-homocysteinylation. J Biol Chem 279(12):10864-10871
3. Jakubowski H (1997) Metabolism of homocysteine thiolactone in human cell cultures. Possible mechanism for pathological consequences of elevated homocysteine levels. J Biol Chem 272(3):1935-1942
4. Jakubowski H (1999) Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J 13(15):2277-2283
5. Jakubowski H (2000) Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans. J Nutr 130(2S Suppl):377S-381S
6. Jakubowski H (2002) Homocysteine is a protein amino acid in humans. Implications for homocysteine-linked disease. J Biol Chem 277(34):30425-30428
7. Jakubowski H (2004) Molecular basis of homocysteine toxicity in humans. Cell Mol Life Sci 61(4):470-487
8. Jakubowski H (2007) The molecular basis of homocysteine thiolactone-mediated vascular disease. Clin Chem Lab Med 45(12):1704-1716
9. Jakubowski H (2008) New method for the determination of protein N-linked homocysteine. Anal Biochem 380(2):257-261
10. Jakubowski H (2011) Quality control in tRNA charging - editing of homocysteine. Acta Biochim Pol 58(2):149-163
11. Jakubowski H (2012) Quality control in tRNA charging. Wiley Interdiscip Rev RNA 3(3):295-310
12. Jakubowski H (2013) Homocysteine in protein structure/function and human disease - chemical biology of homocysteine-containing proteins. Springer, Wien, New York
13. Jakubowski H, Glowacki R (2011) Chemical biology of homocysteine thiolactone and related metabolites. Adv Clin Chem 55:81-103
14. Jakubowski H, Zhang L, Bardeguez A, Aviv A (2000) Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis. Circ Res 87(1):45-51
15. Jakubowski H, Boers GH, Strauss KA (2008) Mutations in cystathionine {beta}-synthase or methylenetetrahydrofolate reductase gene increase N-homocysteinylated protein levels in humans. FASEB J 22(12):4071-4076
16. Jakubowski H, Perla-Kajan J, Finnell RH, Cabrera RM, Wang H, Gupta S, Kruger WD, Kraus JP, Shih DM (2009) Genetic or nutritional disorders in homocysteine or folate metabolism increase protein N-homocysteinylation in mice. Faseb J 23(6):1721-1727
17. Koopman J, Haverkate F, Grimbergen J, Lord ST, Mosesson MW, DiOrio JP, Siebenlist KS, Legrand C, Soria J, Soria C et al (1993) Molecular basis for fibrinogen Dusart (A alpha 554 Arg->Cys) and its association with abnormal fibrin polymerization and thrombophilia. J Clin Invest 91(4):1637-1643
18. Maclean KN, Gaustadnes M, Oliveriusova J, Janosik M, Kraus E, Kozich V, Kery V, Skovby F, Rudiger N, Ingerslev J, Stabler SP, Allen RH, Kraus JP (2002) High homocysteine and thrombosis without connective tissue disorders are associated with a novel class of cystathionine beta-synthase (CBS) mutations. Hum Mutat 19(6):641-655
19. Marchi R, Lundberg U, Grimbergen J, Koopman J, Torres A, de Bosch NB, Haverkate F, Arocha Pinango CL (2000) Fibrinogen Caracas V, an abnormal fibrinogen with an A alpha 532 Ser->Cys substitution associated with thrombosis. Thromb Haemost 84(2):263-270
20. Marczak L, Sikora M, Stobiecki M, Jakubowski H (2011) Analysis of site-specific N-homocysteinylation of human serum albumin in vitro and in vivo using MALDI-ToF and LC-MS/MS mass spectrometry. J Proteomics 74(7):967-974
21. Maron BA, Loscalzo J (2009) The treatment of hyperhomocysteinemia. Annu Rev Med 60:39-54
22. Mosesson MW, Sherry S (1966) The preparation and properties of human fibrinogen of relatively high solubility. Biochemistry 5(9):2829-2835
23. Mudd SH, Levy HL, Kraus JP (2001) Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS (eds) The metabolic and molecular bases of inherited disease, vol 2. Mc Graw-Hill, New York, pp 2007-2056
24. Orendae M, Pronicka E, Kubalska J, Janosik M, Sokolova J, Linnebank M, Koch HG, Kozich V (2004) Identification and functional analysis of two novel mutations in the CBS gene in Polish patients with homocystinuria. Hum Mutat 23(6):631
25. Paoli P, Sbrana F, Tiribilli B, Caselli A, Pantera B, Cirri P, De Donatis A, Formigli L, Nosi D, Manao G, Camici G, Ramponi G (2010) Protein N-homocysteinylation induces the formation of toxic amyloid-like protofibrils. J Mol Biol 400(4):889-907
26. Perla-Kajan J, Stanger O, Luczak M, Ziolkowska A, Malendowicz LK, Twardowski T, Lhotak S, Austin RC, Jakubowski H (2008) Immunohistochemical detection of N-homocysteinylated proteins in humans and mice. Biomed Pharmacother 62(7):473-479
27. Sauls DL, Lockhart E, Warren ME, Lenkowski A, Wilhelm SE, Hoffman M (2006) Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia. Biochemistry 45(8):2480-2487
28. Sikora M, Marczak L, Twardowski T, Stobiecki M, Jakubowski H (2010) Direct monitoring of albumin lysine-525 N-homocysteinylation in human serum by liquid chromatography/mass spectrometry. Anal Biochem 405(1):132-134
29. Sikora M, Marczak L, Suszynska-Zajczyk J, Jakubowski H (2012) Monitoring site-specific N-homocysteinylation in fibrinogen in vitro and in vivo as a potential marker of thrombosis in CBS-deficient patients. In: 22nd International Fibrinogen Workshop, Brighton, UK, International Fibrinogen Research Society (IFRS)
30. Undas A, Perla J, Lacinski M, Trzeciak W, Kazmierski R, Jakubowski H (2004) Autoantibodies against N-homocysteinylated proteins in humans: implications for atherosclerosis. Stroke 35(6):1299-1304
31. Yang X, Gao Y, Zhou J, Zhen Y, Yang Y, Wang J, Song L, Liu Y, Xu H, Chen Z, Hui R (2006) Plasma homocysteine thiolactone adducts associated with risk of coronary heart disease. Clin Chim Acta 364(1-2):230-234
32. Zang T, Dai S, Chen D, Lee BW, Liu S, Karger BL, Zhou ZS (2009) Chemical methods for the detection of protein N-homocysteinylation via selective reactions with aldehydes. Anal Chem 81(21):9065-9071